Portfolio company
Probius
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops bioanalytical platforms using quantum electrochemical spectroscopy to provide biochemical data for pharmaceutical, biotechnology and healthcare researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
QDTI
This company develops quantum sensing instruments for biomarker detection used by researchers, pharmaceutical companies and clinicians for drug discovery and diagnostic testing.
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
Quanterix
This company develops ultra-sensitive biomarker detection platforms and assay kits for pharmaceutical companies, academic institutions, and clinical laboratories.
Nplex Biosciences
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
Causeway Sensors
This company develops plasmonic nanostructure sensors for real-time bioprocess monitoring and drug manufacturing data collection for pharmaceutical companies.
Spectacell
This company develops a label-free single-cell analysis platform for pharmaceutical and biotechnology organisations to measure the performance of immune therapies.
Palamedrix
This company develops DNA nanotechnology and biosensor platforms for multi-omic detection and proteomic analysis for biopharmaceutical and academic research markets.
Protuoso Biosciences
This company develops multifunctional recombinant fusion proteins for pharmaceutical researchers and clinicians treating cardiometabolic, oncological and autoimmune diseases.
